Targeting the Epigenetic Marks in Type 2 Diabetes Mellitus: Will Epigenetic Therapy Be a Valuable Adjunct to Pharmacotherapy?

Chioma Laura Odimegwu,1 Samuel Nkachukwu Uwaezuoke,1 Ugo N Chikani,1 Ngozi Rita Mbanefo,1 Ken Daberechi Adiele,1 Charles Emeka Nwolisa,2 Chizoma Ihuarula Eneh,3 Chibuzo Obiora Ndiokwelu,1 Somkenechi C Okpala,1 Francis N Ogbuka,3 Kenneth E Odo,1 Ijeoma Onyinyechukwu Ohuche,1 Chinelo Elizabeth Obiora-...

Full description

Bibliographic Details

Published in:	Diabetes, Metabolic Syndrome and Obesity
Main Authors:	Odimegwu CL, Uwaezuoke SN, Chikani UN, Mbanefo NR, Adiele KD, Nwolisa CE, Eneh CI, Ndiokwelu CO, Okpala SC, Ogbuka FN, Odo KE, Ohuche IO, Obiora-Izuka CE
Format:	Article
Language:	English
Published:	Dove Medical Press 2024-09-01
Subjects:	type 2 diabetes mellitus epigenetics dna methylation histone modifications noncoding rna regulation therapeutics epigenetic therapy
Online Access:	https://www.dovepress.com/targeting-the-epigenetic-marks-in-type-2-diabetes-mellitus-will-epigen-peer-reviewed-fulltext-article-DMSO